Holen Sie sich die Stockscreener-App
2.9228
2.90%
-0.0872
Handel nachbörslich:
2.92
-0.0028
-0.10%
Finanzdaten der Aprea Therapeutics Inc-Aktie (APRE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
2,604%
0.3806
|
0.0141 | 0.3195 | 0.2497 | - |
| Operating Expenses |
4.30%
3.5302
|
3.689 | 3.8423 | 3.9014 | 4.6225 |
| Benefits Costs and Expenses |
7.71%
3.1907
|
3.4573 | 3.524 | 3.5088 | 4.3799 |
| Costs And Expenses |
4.30%
3.5302
|
3.689 | 3.8423 | 3.9014 | 4.6225 |
| Operating Income/Loss |
14.29%
-3.1497
|
-3.6749 | -3.5229 | -3.6517 | -4.6225 |
| Income/Loss From Continuing Operations Before Tax |
18.39%
-2.8101
|
-3.4433 | -3.2045 | -3.2591 | -4.3799 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
18.39%
-2.8101
|
-3.4433 | -3.2045 | -3.2591 | -4.3799 |
Net Income/Loss
|
18.39%
-2.8101
|
-3.4433 | -3.2045 | -3.2591 | -4.3799 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10,363%
4.1983
|
0.0401 | 3.7352 | 3.7316 | 3.2605 |
| Diluted Average Shares |
10,056%
4.1983
|
0.0413 | 3.7316 | 3.7316 | 3.2605 |
| Basic Earnings Per Share |
27.17%
-0.67
|
-0.92 | -0.86 | -0.87 | -1.34 |
| Diluted Earnings Per Share |
27.17%
-0.67
|
-0.92 | -0.85 | -0.87 | -1.34 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):